Clinical Trial

Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement

Study acronym: ROHMA
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness, feasibility, and safety of mandibular advancement devices (MAD) for treating severe obstructive sleep apnea (OSA) in patients who are CPAP intolerant and have failed hypoglossal nerve stimulation (HGNS).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-18; most recent amendment 2026-03-18.
Trial Details
NCT Number NCT07132307
Lead Sponsor Washington University School of Medicine
Conditions Obstructive Sleep Apnea
Enrollment 30 participants
Start Date 2025-07-29
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-19